HARVEY NORMAN HOLDINGS LIMITED (HVN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HVN - HARVEY NORMAN HOLDINGS LIMITED

FNArena Sector : Consumer Electronics
Year End: June
GICS Industry Group : Retailing
Debt/EBITDA: 1.69
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Harvey Norman is a multinational retailer of household products, electronics and consumer electrical goods. The present company formed in 1982 and listed on the ASX in 1987.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.72

23 Mar
2023

-0.040

OPEN

$3.76

-1.06%

HIGH

$3.78

4,113,985

LOW

$3.71

TARGET
$4.043 8.7% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
DSH . JBH . AUA . AMS .
FNARENA'S MARKET CONSENSUS FORECASTS
HVN: 1
Title FY21
Actual
FY22
Actual
FY23
Forecast
FY24
Forecast
EPS (cps) xxx 65.1 43.1 xxx
DPS (cps) xxx 37.5 28.7 xxx
EPS Growth xxx - 3.6% - 33.8% xxx
DPS Growth xxx 7.1% - 23.5% xxx
PE Ratio xxx N/A 8.6 xxx
Dividend Yield xxx N/A 7.7% xxx
Div Pay Ratio(%) xxx 57.6% 66.5% xxx

Dividend yield today if purchased 3 years ago: 14.37%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

10.11

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 14/10 - ex-div 17.5c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx65.1
DPS All xxxxxxxxxxxxxxx37.5
Sales/Revenue xxxxxxxxxxxxxxx4,143.6 M
Book Value Per Share xxxxxxxxxxxxxxx342.0
Net Operating Cash Flow xxxxxxxxxxxxxxx597.3 M
Net Profit Margin xxxxxxxxxxxxxxx19.59 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx19.97 %
Return on Invested Capital xxxxxxxxxxxxxxx14.93 %
Return on Assets xxxxxxxxxxxxxxx11.66 %
Return on Equity xxxxxxxxxxxxxxx19.97 %
Return on Total Capital xxxxxxxxxxxxxxx16.40 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx66.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201720182019202020212022
Short-Term Debt xxxxxxxxxxxxxxx400 M
Long Term Debt xxxxxxxxxxxxxxx1,504 M
Total Debt xxxxxxxxxxxxxxx1,904 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx249 M
Price To Book Value xxxxxxxxxxxxxxx1.08

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201720182019202020212022
Capex xxxxxxxxxxxxxxx94.9 M
Capex % of Sales xxxxxxxxxxxxxxx2.29 %
Cost of Goods Sold xxxxxxxxxxxxxxx2,027 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx1,146 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx3,968 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

-0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

01/03/2023

1

Outperform

$5.26

41.40%

Despite a first half result well above consensus expectations from Harvey Norman, Credit Suisse highlights the market is concerned about a high level of excess inventory at the close of the half. The company claims excess stock is seasonal and will be carried into the first half of the next fiscal year, but commentary has done little to appease.

A January sales update also indicated domestic franchisee sales declined to 8% above pre-covid levels, from 15% above pre-covid levels in the second quarter, with deceleration greater than expected. 

The Outperform rating is retained and the target price decreases to $5.26 from $5.40.

Morgan Stanley

xx/xx/xxxx

5

xxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

HVN STOCK CHART